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ABSTRACT
Background: We aimed to determine the effects of  Anethum 
graveolens (Dill) powder on postprandial lipid profile, markers of  
oxidation and endothelial activation when added to a fatty meal.
Methods: In an experimental study, 32 rabbits were randomly 
designated into four diet groups: normal diet, high cholesterol 
diet (1%), high cholesterol diet plus 5% (w/w) dill powder 
and high cholesterol diet plus lovastatin (10 mg/kg, bw). The 
concentrations of  glucose, total cholesterol (TC), low‑density 
lipoproteins‑cholesterol (LDL‑C), alanine aminotransferase (alt), 
aspartate aminotransferase (ast), fibrinogen, factor VII, 
apolipoprotein B (ApoB), nitrite and nitrate were measured in 
blood samples following 15 h of  fasting and 3 h after feeding.
Results: Concurrent use of  A. graveolens powder or lovastatin 
significantly decreased ALT, TC, glucose, fibrinogen and 
LDL‑C values in comparison with hypercholesterolemic diet 
group (P < 0.05). Consumption of  A. graveolens or lovastatin did 
not change factor VII, ApoB, nitrite and nitrate levels significantly 
in comparison with hypercholesterolemic diet group. Intake 
of  A. graveolens significantly decreased serum AST compared to 
hypercholesterolemic diet.
Conclusions: A. graveolens might have some protective values 
against atherosclerosis and that it significantly affects some 
biochemical risk factors of  this disease. Our findings also confirm 
the potential harmful effects of  oxidized fats and the importance 
of  dietary polyphenols in the meal.
Keywords:  Anethum graveolens, atherosclerosis, hypercholesterolemia, 
rabbits
INTRODUCTION
Hyperlipidemia promotes atherosclerosis, which is a syndrome 
affecting arterial blood vessels, a chronic inflammatory response 
in the walls of  arteries, caused largely by the accumulation of  
macrophage white blood cells and promoted by low‑density 
lipoproteins (LDL) without adequate removal of  fats and 
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cholesterol from the macrophages by functional 
high‑density lipoproteins (HDL). It is caused by the 
formation of  multiple plaques within the arteries.[1]
Atherosclerosis is a chronic disease that remains 
asymptomatic for a long time.[2] Upon formation, 
intraluminal thrombi can occlude arteries 
outright (i.e., coronary occlusion), but more often 
they detach, move into the circulation and eventually 
occlude smaller downstream branches causing 
thromboembolism. Apart from thromboembolism, 
atherosclerotic lesions can cause complete closure 
of  the arteries. Interestingly, chronically expanding 
lesions are often asymptomatic until the artery 
stenosis is so severe that the blood supply to 
downstream tissue (s) is insufficient and results in 
ischemia.[3]
Various, physiological, anatomic and behavioral 
risk factors for atherosclerosis are known. Diabetes 
or impaired glucose tolerance, dyslipoproteinemia, 
high serum concentration of  LDL and/or very 
low density lipoprotein (VLDL), Low serum 
concentration of  functioning HDL, LDL:HDL 
ratio greater than 3:1, elevated serum C‑reactive 
protein concentrations, elevated lipid peroxidation, 
are among the most important modifiable risk 
factors of  atherosclerosis.[4‑6]
Hyperlipidemia and lipid peroxidation are 
more than others implicated in induction of  
atherosclerosis. As humans are predominantly 
in a postprandial state, attention has been paid, 
recently, on postprandial hyperlipidemia and its 
abnormalities on the contributing factors leading 
to atherosclerosis.[7‑9]
Evidence suggests that postprandial hypertrigly‑
ceridemia is a risk factor for cardiovascular disease 
(CVD)[10] and that it has a negative effect on 
endothelial function in normal subjects.[7,11,12]
It has also shown that medicinal plants, rich in 
antioxidants, may ameliorate hyperlipidemia,[13‑15] 
other than reduction of  diabetic or atherosclerosis 
complications.[16] These plants mostly include 
phenolic and flavonoid components with 
antioxidant activities.[15]
It has also been shown that flavonoid‑containing 
food such as fruits, vegetables and tea are protective 
against CVD through their free radical‑scavenging 
quality.[17] As it was mentioned scientists mostly 
attribute these effects to flavonoids potential role 
in decreasing blood lipid levels and therefore 
changing the postprandial state.[10,18]
Dill is a short‑lived perennial herb and is the sole 
specie of  the genus Anethum. Its seeds contain 3% 
oil, carotene, flandrenin, limonene and tannin. In 
traditional Iranian medicine, Dill has been used as 
sedative, carminative, antispasmodic, lactogogue, 
diuretic and home remedy for hyperlipidemia.[19]
It has been found that other than glucose, 
dill significantly may reduce triglyceride, total 
cholesterol (TC), VLDL, LDL‑cholesterol (LDL‑C) 
and increases HDL‑cholesterol (HDL‑C) in 
diabetic rats. These effects have also been attributed 
to antioxidant contents of  dill.[20] It seems that 
if  dill reduces postprandial hyperlipidemia, it 
would be beneficial to use in these patients. In 
this study, therefore, we assessed the effects of  
Anethum graveolens powder on postprandial risk 
hyperlipidemia and some other factors leading to 
atherosclerosis in rabbits, fed a high cholesterol diet.
METHODS
Plant preparation
A. graveolens was purchased from the local 
market in Shahrekord, Iran. The genus and species 
were authenticated by a botanist in the Medical 
Plants Research Centre of  Shahrekord University 
of  Medical Sciences and a voucher specimen was 
deposited in the institution herbarium (number 
236). The plants were dried, powdered and 
anthocyanins, flavonoids and phenolic contents 
were measured for standardization as follows.
Measurement of total anthocyanins
A total of  anthocyanins were assayed by 
spectrophotometeric method at 535 nm.[21] A 
total of  3 g of  the sample was weighed in a 
50‑mL centrifuge tube and 24 mL of  acidified 
ethanol (ethanol and HCl 1.0 N, 85:15, v/v) was 
added. The solution was mixed and adjusted to 
pH 1 with 4 N HCl. The resulting solution was 
shaken for 15 min, readjusted to pH 1 if  necessary 
and the solution was shaken for an additional 
15 min. The tube was centrifuged for 15 min, at 
27,200 × g and the supernatant was poured into 
a 50‑mL volumetric flask and made up to volume 
with acidified ethanol. Cyanidin 3‑glucoside was 
used as a standard pigment. A series of  cyanidin 
3‑glucoside standard solutions was prepared at 
0‑0.02 mmol (0‑27 mg/3 mL). Absorbance was 
read at 535 nm against a reagent blank.
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Measurement of total flavonoids
The amount of  flavonoid components in the 
Anethum extract was evaluated by colorimetric 
method.[22] Thus, 0.5 mL of  rutin (standard 
flavonoid compound) or garlic extract was added 
to a flask containing 1.5 mL of  methanol, 2.8 mL 
of  distilled water, 0.1 mL of  1 M potassium 
acetate, 0.1 mL of  10% aluminum chloride 
and left at room temperature for 30 min. The 
reaction absorbance was measured at 415 nm after 
preparing a standard curve from rutin solutions at 
concentrations of  25‑500 ppm in methanol. The 
experiment was repeated in triplicate. The total 
flavonoid components were expressed in terms of  
rutin equivalents (in mg/g).
Measurement of total phenolic compounds
The amount of  total phenolic components in the 
Anethum extract was determined colorimetrically 
using the Folin‑Ciocalteu reagent.[23,24] in brief, 
5 mL of  gallic acid (standard phenolic compound) 
or Anethum extract was mixed with Folin‑Ciocalteu 
reagent diluted with distilled water (1:10) and 
aqueous Na
2
CO
3 
(4 mL, 1 M). The mixture was 
left to stand for 15 min and the total phenolic 
compounds were determined by colorimetry at 
765 nm. A standard curve was prepared from 
different concentrations (0‑250 mg/L) of  gallic 
acid in methanol: water (50:50, vol/vol). The 
experiment was repeated in triplicate and the total 
phenolic values were expressed in in mg/g of  gallic 
acid equivalent.
Treatment of rabbits
This study was approved by the ethics committee 
of  Shahrekord University of  Medical Sciences. 
32 male white New Zealand rabbits weighing 
2010 ± 275 g were obtained from Razi Vaccine 
and Serum Research Institute in Iran. They were 
kept in an air‑conditioned room for 2 weeks and 
allowed water and standard rabbit chow containing 
16% protein, 4‑5% vegetable fat, 13% fiber, 1.4% 
calcium, 0.8% phosphor, 0.5% cysteine and 0.5% 
tryptophan.[25]
The rabbits were randomized into four groups 
of  eight and fed a diet as follows: group I: normal 
diet, Group II: diet containing 1% cholesterol, 
Group III: a high cholesterol diet containing 5% 
dill powder and Group IV: high cholesterol (1%) 
plus lovastatin (10 mg/kg bw).
After fasting for 12‑15 h, venous blood samples 
were taken to obtain baseline data. Venous blood 
samples were also obtained 3 h after the diet to 
determine the acute effects of  A. graveolens.[10]
Measurement of biochemical factors in rabbits
Serum and plasma samples were collected by 
centrifuging blood samples at 3500 rpm for 20 min. 
Fibrinogen and factor VII values were obtained 
through the plasma and the serum was used for 
other biomarker measurements.
Serum TC, LDL‑C, apolipoprotein B (ApoB), 
alanine aminotransferase (alt), aspartate 
aminotransferase (ast) and serum glucose were 
determined using standard enzymatic kits 
(Pars Azmoon Co, Iran) and an auto‑analyzer 
(Hitachi 902, Japan). Factor VII was measured 
using clotting time, in the presence of  the 
STA‑Neoplastine reagent of  a system in which all 
factors were present, constant and in excess except 
factor VII, which is derived from the sample being 
tested (Diagnostic Stago, French). The serum 
levels of  nitrite and nitrate were measured using 
a colorimetric assay kit (R and D Systems, USA), 
which involves the Griess reaction.
Statistical analysis
Results were analyzed using Instat 3 software. To 
investigate the biochemical results and comparison 
of  the experimental groups, Kruskal‑Wallis and 
Dunn tests were used and P < 0.05 was considered 
statistically significant.
RESULTS
Determination of some physiochemical factors 
in A. graveolens
Analyzing A. graveolens factors showed that the 
amounts of total anthocyanins, flavonoids and 
phenolic compounds in the extract were 94 mg/100 g, 
62 mg/100 g (equivalent to gallic acid) and 
95 mg/100 g (equivalent to gallic acid), respectively.
Measurement biochemical factors in rabbit
Consumption of  A. graveolens powder or 
lovastatin significantly decreased ALT, TC, 
glucose, fibrinogen and LDL‑C values in 
comparison with hypercholesterolemic diet 
group [Table 1]. Concurrent use of  A. graveolens or 
lovastatine did not change factor VII, ApoB, nitrite 
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and nitrate levels significantly in comparison 
with hypercholesterolemic diet group. Intake 
of  A. graveolens significantly decreased serum 
AST compared with hypercholesterolemic 
diet [Table 1].
DISCUSSION
The association between postprandial 
triglyceride and atherosclerosis has been confirmed 
by various studies.[10,26] Evidence suggests that 
postprandial lipoproteins induce the expression 
and release of  endothelial mediators in vitro and 
that this metabolic syndrome is associated with 
humeral risk markers of  endothelial origin.[27‑30]
Recently, the importance of  therapeutic plants 
has become the focus of  many studies. Vegetables, 
fruits and their juices contain phenolic compounds, 
which have antioxidant properties and are 
protective against atherosclerosis.[31,32]
In a study, the hypolipidemic effects of  
powdered dill and its special oil (which is the main 
constituent of  this plant) was investigated in male 
rats fed a high cholesterol diet. The results of  this 
study showed that adding powdered dill to rat’s diet 
for 2 weeks significantly reduced TC, triglyceride 
and LDL‑C and also significantly increased 
HDL‑C levels.[33] In the present study, we assessed 
the effects of  A. graveolens powder on postprandial 
risk factors leading to atherosclerosis in rabbits fed 
a high cholesterol diet. In this study, lovastatin was 
used to compare the effects of  standard drug with 
dill. Statins reduce the cholesterol content from 
lipoporoteins by their hypercholestric effects and 
also deplete the amount of  oxidable compounds.[32]
Lovastatin attaches to phospholipids on LDL 
surface and therefore prevents the diffusion of  free 
radicals under oxidative pressure to the core of  
lipoproteins.[34]
By significantly reducing LDL‑C, cholesterol, 
glucose, ALT, AST values in A. graveolens seems to 
have the potential to protect against coronary artery 
disease. It decreases LDL‑C and cholesterol levels 
by either upregulating lipoprotein lipase, which 
hydrolyses triglycerides or reducing the hepatic 
VLDL production or by reducing the activity of  
two enzymes involved in cholesterol metabolism 
(3‑hydroxy‑3 methyl glutaryl coenzyme A 
reductase and/or acyl cholesterol acyl transferase). 
Acyl cholesterol acyl transferase catalyses the 
intracellular esterification of  cholesterol and 
plays a role in cholesterol absorption and hepatic 
secretion of  VLDL and ApoB.[35]
The glucose reducing effects of  powdered dill 
can be due to the following:[36,37]
•	 The	 presence	 of 	 flavonoids,	 which	 inhibits	
glucose absorption in the intestine
•	 Flavonoids	 block	 the	 enzyme	 glucose	 6	
phosphatase and therefore reduce blood glucose 
levels. This enzyme mediates separation of  
phosphate from phosphorylated glucose and 
therefore releases glucose into the blood stream.
Table 1: Comparison of LDL‑C, factor VII, ApoB, TC, AST, ALT, glucose, nitrite, nitrate and fibrinogen values at the end of 
experiment
Biochemical 
factors
Groups
Cholesterolemic diet Lovastatin Anethum graveolens Normal diet
LDL‑C (mg/dl) 39.31±3.20 15.81±2.50* 15.10±2.16* 24.31±1.26*
TC (mg/dl) 91±3.37 65.43±3.21* 67.25±2.76* 56.63±0.68*
ALT (mg/dl) 40±1.34 36.43±2.25* 32.25±1.33* 26.63±0.50*
AST (mg/dl) 43.22±2.63 35.86±1.03 32.22±1.42* 29.75±0.53*
Glucose (mg/dl) 132±3.57 113.71±4.96* 103.13±4.26* 51.25±3.12*
Factor VII 298.1±5.7 292.5±2.5 293.8±1.8 295.7±2.5
Nitrite (μmol/l) 249.3±10.4 214.1±30 252±13.7 250.4±10
Nitrate (μmol/l) 430±36.7 324.6±44.8 439±39.7 305.6±108.8
Fibrinogen 251±4.6 221.3±3.2* 220.3±2.9* 216.6±2.6*
ApoB (mg/dl) 30.78±1.02 34.43±1.09 32.86±2.07 27.88±0.88
Mean total cholesterol, ApoB100=Apolipoprotein B100, nitrite, nitrate, factor VII, glucose, LDL=Low‑density lipoprotein, 
fibrinogen, alt=Alanine aminotransferase, ast=Aspartate aminotransferase, SEM=Standard error of mean, in each 
group (n=8 for each experimental group) *P<0.05, comparison between cholesterolemic diet group and each of other three 
groups (Anethum graveolens, lovastatin and normal diet). Results are expressed as mean±SEM
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Nitric oxide (NO) is the most important vasodilator 
derived from the endothelium. NO produced by 
endothelial nitric oxide synthase (eNOS) has a 
significant role in the initiation of  coronary vessel 
hemostasis, whereas NO produced by inducible 
nitric oxide synthase (iNOS) causes CVD. iNOS is 
an enzyme produced by various cells and mediated 
by cytokines in inflammatory conditions.[38‑44] 
Anthocyanins reduce iNOS expression and 
increase the expression of  eNOS and thus play a 
role in the equilibrium between iNOS and eNOS 
in different pathologic systems.[45] In the present 
study, its blood level was not changed, perhaps due 
to shortage of  the experiment.
Studies indicate the role of  vegetarian diets in 
the hemostasis of  coagulation and fibrinolysis. 
These compounds are effective in reducing 
coagulation factors, increasing fibrinolysis 
and decreasing blood coagulation by reducing 
fibrinogen, inhibiting platelet aggregation and 
increasing prothrombin time.[46] In the present 
study consumption of  A. graveolens powder, similar 
to lovastatin, significantly decreased fibrinogen 
compared with hypercholesterolemic diet group.
The results of  this study indicate that 
consumption of  A. graveolens can decreases the 
negative effects of  postprandial cholesterol rich 
diet. Considering the price and the availability of  
A. graveolens, this plant seems to be an effective 
choice for preventing some of  the risk factors of  
atherosclerosis.
CONCLUSIONS
A. graveolens decreases the postprandial 
atherosclerosis risk factors and might be beneficial 
in hyperchlesterolemic patients. Considering the 
price and availability of  A. graveolens, this plant 
seems to be an effective choice for hyperlipidemia, 
especially for reducing postprandial risk factors of  
atherosclerosis. However, the mechanism of  action 
and the structures of  the active ingredients should be 
established. These are our focus for future studies. 
Further studies are also need to be performed to 
determine similar effects of  A. graveolens in human.
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